Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Todd Suscovich
SeromYx Systems
United States
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
62
TOTAL CITATIONS
1
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Therapeutic Potential of SARS-CoV-2-Specific Monoclonal Antibody CR3022
Number of pages: 15
Posted: 01 Jun 2020
Caroline Atyeo
,
Matthew D. Slein
,
Stephanie Fischinger
,
John Burke
,
Alexandra Schӓfer
,
Sarah R. Leist
,
Anna Honko
,
Rebecca Johnson
,
Nadia Storm
,
Matthew Bernett
,
Caitlyn Linde
, Todd Suscovich,
Anthony Griffiths
,
John R. Desjarlais
,
Boris D. Juelg
,
Jaap Goudsmit
,
Ralph Baric
and
Galit Alter
Ragon Institute of MGH, MIT and Harvard, Ragon Institute of MGH, MIT and Harvard, Ragon Institute of MGH, MIT and Harvard, Ragon Institute of MGH, MIT and Harvard, University of North Carolina (UNC) at Chapel Hill - Department of Epidemiology, University of North Carolina (UNC) at Chapel Hill - Department of Epidemiology, Boston University - Department of Microbiology, Boston University - Department of Microbiology, Boston University - Department of Microbiology, Xencor, SeromYx Systems, SeromYx Systems, Boston University - Department of Microbiology, Xencor, Ragon Institute of MGH, MIT and Harvard, Harvard University - Department of Epidemiology, University of North Carolina (UNC) at Chapel Hill - Department of Microbiology and Immunology and Ragon Institute of MGH, MIT and Harvard
Downloads
62
(942,565)
Citation
1
View PDF
Download
Abstract:
SARS-CoV-2, antibody effector function, immunity, Fc function, CR3022
Feedback